Filing Details
- Accession Number:
- 0001567619-22-013253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-22 17:03:42
- Reporting Period:
- 2022-06-17
- Accepted Time:
- 2022-06-22 17:03:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1628171 | Revolution Medicines Inc. | RVMD | Biological Products, (No Disgnostic Substances) (2836) | 472029180 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1849181 | Xiaolin Wang | C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-17 | 665 | $17.75 | 31,970 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
- Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.
- Includes 26,450 RSUs.